NCT06499272Completed
Quality-of-Life-and-Cognitive-Oriented Rehabilitation Through the NeuronUP in Alzheimer's Disease
Quality-of-Life-and-Cognitive-Oriented Rehabilitation Program Through the NeuronUP in Older People With Alzheimer's Disease: A Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 12 Jul 2024
Brief summary (registry, in English)
Introduction: New technologies are a support in the rehabilitation of users. The therapeutic approach to cognitive rehabilitation encompasses a variety of techniques, among which traditional occupational therapy stands out. This modality includes a series of interventions such as cognitive stimulation through the use of cards, functional activities, psychomotor exercises, the application of sensory stimuli and the incorporation of music therapy. An additional alternative is to integrate a cognitive stimulation program such as NeuronUP, which is a computerized tool. This integration can increase adherence to treatment and contribute to preserving or improving the individual's cognitive functioning and improving quality of life. Objective: The objective established for this study was to verify whether the combination of occupational therapy with the NeuronUP computer program improves or maintains the cognitive status and quality of life of users with Alzheimer's disease. In addition, to determine whether the use of this program leads to greater adherence to treatment by patients. Material and methods: This is a randomized clinical trial. Participants' cognitive status will be assessed using the MEC (Mini Cognitive Examination) tool, cognitive skills using the LOTCA (Loewenstein Occupational Therapy Cognitive Assessment), and perceived quality of life using the Whoqol-Bref questionnaire. At the end of treatment, the CSQ-8, a tool designed to determine the degree of user satisfaction, will be administered.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 6 Jul 2024
- Start date
- 1 Dec 2023
- Primary completion date
- 1 Jul 2024
- Lead sponsor
- Universidad Rey Juan Carlos
- Diseases
- Alzheimer disease
- NCT number
- NCT06499272
What you commit to
- Study type: Interventional
- Participants enrolled: 35
- From 1 Dec 2023 to the primary completion date, 1 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not attending Occupational Therapy sessions regularly.
Other illness
- Having severe cognitive impairment, as measured by the Mini Cognitive Examination (MEC\<22 points).
- Having comorbid diagnoses such as stroke, brain tumours or heart disease, among others.
Other
- Poor adherence to the treatments offered at the centre.
- Not agreeing to participate voluntarily in the study.
Who the study is looking for
- Adult men or women, aged 65 years or olde.
- Not present severe cognitive impairment, measured through the Mini Cognitive Examination test (MEC\>22 points).
- To reside permanently in the Nursing Home.
- Attend Occupational Therapy sessions regularly.
- Have adequate manual dexterity to be able to use a Tablet.
- Agree to participate voluntarily in the study.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Physiocare Madrid Clinic Coordinator of this site? Confirm its status | Madrid | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.